Skip to main content
. 2020 Feb 19;5(1):e00984-19. doi: 10.1128/mSphere.00984-19

TABLE 1.

Clinical information for the four patient groups

Characteristica Data for group:
FT FTA PT PTA
No. of vaginal samples 18 18 22 24
No. of meconium samples 21 26 21 24
No. of maternal GBS infections 0 5 0 2
No. of premature rupture of membranes 0 21 7 20
No. with amniotic fluid contamination (grade III) 3 8 4 0
Gestational age (mean ± SD) (wk) 39.42 ± 0.91 39.22 ± 1.03 35.17 ± 1.31 34.96 ± 1.51
Neonatal sex (no. of males: no. of females) 16:8 15:12 13:11 11:14
Neonatal wt (mean ± SD) (g) 3,106.25 ± 348.72 3,368.52 ± 344.93 2,558.33 ± 405.03 2,471.60 ± 329.27
Neonatal WBC count (mean ± SD) (109/liter) 20.10 ± 5.51 18.20 ± 7.19 13.75 ± 6.85 12.57 ± 5.39
Neonatal CRP (mean ± SD) (mg/liter) 1.23 ± 1.26 3.69 ± 8.98 0.99 ± 1.82 2.284 ± 6.34
No. with low birth wt 1 0 9 12
No. with early-onset sepsis 0 2 1 1
a

GBS, group B Streptococcus; WBC, white blood cell; CRP, C-reactive protein.